“…Further, the high expression of ACAT1 (HR = 0.44), GLUD1 (HR = 0.41), SLC38A1 (HR = 0.61), and SLC38A2 (HR = 0.63) are significantly correlated with good prognosis in LGG patients, while high expression of AHR (HR = 1.78), ENO1 (HR = 1.69), HK2 (HR = 3.56), MTOR (HR = 1.71), NFATC2 (HR = 2.16), SLC16A4 (HR = 2.92), SLC1A5 (HR = 3.00), SLC36A4 (HR = 1.67), and XBP1 (HR = 1.82) are correlated with poor prognosis in LGG patients. The expression of enolase 1 (ENO1) and hexokinase 2 (HK2) has been shown to play an important role in the occurrence and metastasis of glioma cells [21,22]. Considering individual cancers, the prognoses of eighteen cancers are significantly correlated with at least one MCG.…”